MoneyWorks4Me

Alembic Pharmaceuticals board to consider Audited Financial Results

02 Apr 2014 Evaluate

Alembic Pharmaceuticals has informed that a meeting of the Board of Directors of the Company shall be held on April 28, 2014, to consider and approve the Audited Financial Results of the Company for the Financial Year ended March 31, 2014. Further, the trading window shall remain closed from April 25, 2014 to April 29, 2014 for the above purpose.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..